Eric E. Poma serves as Executive at CytRx Oncology Corp, where they oversee executive responsibilities. Since joining the company, Eric E. Poma has executed 7 insider transactions totaling $50.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 21, 2025 involved purchasing 25,000 shares valued at $50.0K.
Eric E. Poma currently holds 25,000 shares of CytRx Oncology Corp (IVPH.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric E. Poma has been a net buyer of IVPH.OB stock. They have purchased $50.0K and sold $0 worth of shares.
Eric E. Poma's most recent insider trade was on Aug 21, 2025, when they purchased 25,000 shares at $2.00 per share.
Get notified when new Form 4 filings are submitted
| $0.71 |
| Discretionary |
| Apr 27, 2022 | MTEM | $19.4K | Option Exercise | 27,325 | $0.71 | Discretionary |
| Jul 6, 2021 | MTEM | $2.5K | Option Exercise | 3,563 | $0.71 | Discretionary |
| Nov 26, 2018 | MTEM | $64.2K | Option Exercise | 152,945 | $0.42 | Discretionary |
| Nov 26, 2018 | MTEM | $61.7K | Option Exercise | 86,951 | $0.71 | Discretionary |
| Sep 19, 2008 | IVPH.OB | $0 | Disposition | 63,160 | $N/A | Discretionary |